<DESCRIPTION>EXHIBIT 10.26

<TEXT>



<PAGE>



                               LICENSE AGREEMENT



     This License Agreement ("Agreement"), effective as of September 30, 1998,

is made by and between:



     DADE BEHRING INC., a State of Delaware corporation having its principal

office at 1717 Deerfield Road, Deerfield, IL 60015.



                                       and



     PACKARD INSTRUMENT COMPANY, INC., a State of Delaware corporation having

its principal office at 800 Research Parkway, Meriden, Connecticut 06450.



                              W I T N E S S E T H:



     WHEREAS, Dade Behring owns certain patent rights, trade secrets, knowhow

and technology relating to luminescent oxygen channeling immunoassays;



     WHEREAS, Dade Behring and Packard have heretofore entered into a certain

Letter of Intent effective February 28, 1998, as amended (the "LOI"), pursuant

to which Dade Behring granted to Packard a license to use, examine, modify and

enhance the LOCI technology for purposes of determining the feasibility of

commercializing products utilizing such technology, and an option to acquire a

license to utilize such technology in the Field of Use (as hereinafter defined);



     WHEREAS, the parties now desire to enter into this Agreement to further

memorialize their agreements set forth in the LOI and to set forth the terms of

a definitive license agreement, as contemplated by the LOI;



     WHEREAS, in order to avoid potential disputes, Dade Behring has entered

into a license agreement with [* * *] under which Dade Behring received the

right to grant sublicenses in accordance with the Sublicense Agreement (as

defined below), a copy of which is attached hereto as Exhibit A;



     WHEREAS, due to Dade Behring's knowledge, expertise, and experience with

regard to the manufacture of certain products to be used in the practice of

LOCI, Packard and Dade Behring wish to enter into a Supply Agreement (as defined

below), a copy of which is attached hereto as Exhibit B, pertaining to the

supply of such products to Packard for the duration of this Agreement;



     NOW THEREFORE, in consideration of the promises and of the mutual

agreements and covenants herein contained, the parties hereto agree as follows:





[* * *] Indicates information omitted pursuant to a request for confidential

treatment and filed separately with the Securities and Exchange Commission

pursuant to Rule 24b-2 under the Securities Exchange Act of 1934,

as amended.



<PAGE>



I.   DEFINITIONS



     In this Agreement, the following terms shall have the following meanings:



1.1  "Affiliate" shall mean a corporation, company, or other entity of which

     fifty percent (50%) or more of the ownership interest representing the

     right to make the decisions for such corporation, company or entity is, now

     or hereafter, owned or controlled, directly or indirectly, by a Party, but

     such corporation, company, or other entity shall be deemed to be an

     Affiliate only so long as such ownership or control exists.



1.2  "Analyte" shall mean and include any target to be detected by a specific

     binding assay, including without limitation the following classes of

     materials: proteins, deoxyribonucleic acids, ribonucleic acids,

     carbohydrates, bacteria, polynucleotide probes, peptide nucleic acids, and

     small molecules (the latter including but not limited to peptides, drugs,

     steroids, and hormones).



1.3  "Consumables and Supplies" shall mean buffers, microplates, solutions, or

     sample containers and other components that are marketed, packaged, used,

     or sold by Packard and/or its Affiliates explicitly to practice LOCI.



1.4  "Customer" shall mean a Third Party non-Affiliate of Packard.



1.5  "Dade Behring" shall mean and be composed of Dade Behring Inc. and its

     Affiliates.



1.6  "Dade Behring Improvements" shall mean inventions, discoveries, ideas,

     processes, methods, compositions, formulae, techniques, information and

     data, whether or not patentable, conceived, developed or reduced to

     practice after the Effective Date that beneficially change or enhance the

     economic and/or technical attributes of LOCI on which Dade Behring prepares

     an invention record and/or upon which Dade Behring files for patent

     protection. Dade Behring Improvements shall not include information

     relating solely to any instrument developed by Dade Behring that uses LOCI

     technology to the extent that such information is not, and could not

     reasonably be expected to be, used or useful in the Field of Use.



1.7  "Dade Behring Original Technology" shall mean any and all Original

     Technology owned or controlled by Dade Behring including, without

     limitation, the Original Technology which is the subject of Dade Behring

     Patents. For purposes of the foregoing, "controlled by" means possession of

     the ability to grant a license or sublicense as provided for herein without

     violating the terms of any agreement with or other arrangement with any

     Third Party.





                                     Page 2

<PAGE>



1.8  "Dade Behring Patents" shall mean all patents and patent applications

     listed in Exhibit C hereto.



1.9  "Dade Behring Supplemental Technology" shall mean any and all Supplemental

     Technology owned or controlled by Dade Behring after the Effective Date but

Home        Intelligence        Services        Subscriptions        News        About Us

Contact Us       Terms of Use       Resend Documents       Shopping Cart

Copyright © 2008 The Consus Group LLC